Peptide Category Comparison: Glycogen vs Glucagon Explained
Peptide Category Comparison: Glycogen vs Glucagon Explained Glycogen (storage polysaccharide) and glucagon (29-amino acid peptide hormone) serve distinct roles in glucose regulation. Market trends show glucagon-based peptides (e.g., nasal glucagon) growing at 8.2% CAGR (2023-2030), driven by diabetes emergency kits. Key brands: Eli Lilly’s Glucagon Kit vs Xeris’ Gvoke (room-temperature stable). Glucagon advantages: rapid glycogenolysis activation (plasma glucose rise within 10 min); disadvantages: short half-life (3-6 min). Glycogen products (supplements) lack FDA approval; glucagon holds NDA/ANDA certifications. Selection tips: prioritize stability (liquid vs lyophilized) and cold-chain logistics (2-8°C). Industry data: 72% of glucagon patents focus on non-injectable delivery.